Cáncer Medicina Traslacional - GIC 21/116
![Foto de Cáncer Medicina Traslacional - GIC 21/116](/img/grupo.png)
![Foto de Instituto de Investigación Sanitaria Biodonostia](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biodonostia
San Sebastián, EspañaPublicaciones en colaboración con investigadoras/es de Instituto de Investigación Sanitaria Biodonostia (8)
2021
-
Geromirs are downregulated in the tumor microenvironment during colon cancer colonization of the liver in a murine metastasis model
International Journal of Molecular Sciences, Vol. 22, Núm. 9
2020
-
An integrative omics approach reveals involvement of BRCA1 in hepatic metastatic progression of colorectal cancer
Cancers, Vol. 12, Núm. 9, pp. 1-24
-
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
PLoS ONE, Vol. 15, Núm. 3
-
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718
2018
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 27-30
2017
2014
-
Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes
Journal of Pathology, Vol. 232, Núm. 1, pp. 32-42
2013
-
1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death
Translational Psychiatry, Vol. 3, Núm. 1